MESO FY 2011 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$121M+2198468.8% YoY

Gross Profit

$121M100.0% margin

Operating Income

$94M77.5% margin

Net Income

$91M74.9% margin

EPS (Diluted)

$3.90

Cash Flow

Operating Cash Flow

$108M

Free Cash Flow

$108M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$763M

Total Liabilities

$247M

Stockholders' Equity

$516M

Cash & Equivalents

$263M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$5,500	+2198468.8%
Gross Profit	$121M	$5,500	+2198468.8%
Operating Income	$94M	-$10M	+1002.7%
Net Income	$91M	-$15M	+713.0%